1253974

Mark Dacey, M.D. — FEI 3031610524

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 8, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Denver, CO (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
723121 CFR 50.20Consent not obtained, exceptions do not apply
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance